As further support of bone marrow AE's attenuation through fasting, researchers conducting a prospective trial in breast cancer patients fed or fasted prior to chemotherapy found no significant difference in IGF‐1 levels; however, mean erythrocyte and thrombocyte levels significantly higher in the fasted group (7 days post‐treatment).16 This evidence concerns the gene IGF1 and breast carcinoma.